HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and ...

The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...

AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

Beijing assures US and other foreign business leaders that it will continue to open its market to investments and ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

The forum came as Beijing seeks to attract foreign investment as its economy grappled with sluggish domestic consumption and ...